Publication | Closed Access

Anti-TGFβ-1 receptor inhibitor mediates the efficacy of the human umbilical cord mesenchymal stem cells against liver fibrosis through TGFβ-1/Smad pathway

Regenerative MedicineFibrosisLiver FibrosisHepatologyDevelopmental BiologyMedicineLiver PhysiologyAnti-tgfβ-1 Receptor InhibitorStem Cell ResearchStem Cell TherapiesMesenchymal Stem CellHepatology FibrosisMatrix BiologyStem Cell BiologyStem CellsCell BiologyTgfβ-1/smad PathwayHealth Sciences